LRRC53 Activators
Chemical activators of LRRC53 can induce various intracellular signaling pathways through their distinct mechanisms of action, leading to the phosphorylation and activation of this protein. Phorbol 12-myristate 13-acetate (PMA) acts by activating protein kinase C (PKC), which phosphorylates a variety of target proteins, potentially including LRRC53. Ionomycin, by serving as an ionophore for calcium, raises intracellular calcium levels, which can trigger calcium-sensitive signaling cascades and the subsequent phosphorylation of LRRC53. Similarly, Thapsigargin, by inhibiting the SERCA pump, elevates cytosolic calcium levels, possibly leading to the activation of LRRC53 through calcium-dependent kinases. Forskolin, through the elevation of cAMP levels via adenylyl cyclase stimulation, activates PKA, which can also target LRRC53 for phosphorylation. Dibutyryl-cAMP (db-cAMP), a cAMP analog, permeates cell membranes and activates PKA, which can again phosphorylate and activate LRRC53.
Additional chemicals such as Okadaic Acid and Calyculin A, both inhibitors of protein phosphatases, can lead to an increase in the phosphorylation state of cellular proteins, which in turn can result in the activation of LRRC53. Pervanadate, as an inhibitor of tyrosine phosphatases, can also contribute to the activation of LRRC53 by increasing tyrosine phosphorylation. Anisomycin activates stress-activated protein kinases, such as JNK, which may then phosphorylate LRRC53 as part of the cellular stress response. KN-93, which inhibits CaMKII, can lead to the activation of pathways involving the phosphorylation of LRRC53, while H-89, despite being a PKA inhibitor, has off-target effects that can activate pathways that phosphorylate LRRC53. Epigallocatechin gallate (EGCG), known to modulate kinase signaling pathways, can also play a role in the phosphorylation and activation of LRRC53. These diverse chemicals, through their unique interactions with cellular enzymes and signaling molecules, contribute to the modulation of LRRC53 activity within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which is known to phosphorylate a wide range of target proteins. Since PKC activation often leads to downstream activation of proteins involved in cellular signaling, LRRC53, as a protein possibly influenced by PKC signaling, would be functionally activated as a consequence of PMA's action on PKC. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as an ionophore for calcium, increasing intracellular calcium concentration. Elevated calcium levels can activate calcium-sensitive signaling pathways, which may include kinases or other effectors that directly phosphorylate and activate LRRC53. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 and 2A. By inhibiting these phosphatases, Okadaic Acid leads to increased phosphorylation of proteins within the cell. This would result in the sustained activation of LRRC53 if it is a substrate for these phosphatases. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a membrane-permeable cAMP analog that activates PKA. The activation of PKA can then phosphorylate and activate LRRC53 directly if it is a target of PKA or as part of a broader phosphorylation-dependent signaling pathway. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium levels. Elevated calcium can activate calcium-dependent kinases that may phosphorylate and activate LRRC53. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is known to activate stress-activated protein kinases such as JNK. Activation of these kinases can lead to the phosphorylation and activation of target proteins, including LRRC53, as part of the stress response signaling pathways. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is a selective inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII). However, its binding to CaMKII can lead to paradoxical effects, ultimately leading to activation of pathways that include phosphorylation of LRRC53. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to Okadaic Acid, Calyculin A is an inhibitor of protein phosphatases, particularly PP1 and PP2A. This inhibition can lead to the prolonged phosphorylation and resultant activation of downstream proteins, which may include LRRC53. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG has been shown to modulate various signaling pathways, including those involving kinases. The interaction of EGCG with these kinases can lead to the phosphorylation and functional activation of proteins within these pathways, potentially including LRRC53. | ||||||